Urgent Alert: Contaminated Propylene Glycol Detected in Medical Products

Attention healthcare professionals and regulatory authorities! Falsified (contaminated) USP/EP PROPYLENE GLYCOL has been detected in the WHO Eastern Mediterranean Region, specifically in Pakistan. The contaminated raw materials, not manufactured or supplied by DOW as confirmed, contain dangerously high levels of ethylene glycol, posing a severe health risk, particularly to children. Ethylene glycol ingestion can lead ...

WHO’s Essential Tool: Tackling Antimicrobial Resistance with MIA

WHO has released the “WHO List of Medically Important Antimicrobials (MIA)” as a crucial tool to combat antimicrobial resistance (AMR) from non-human use. This guidance supports decision-making for authorities, veterinarians, and agricultural professionals to minimize AMR impact. The MIA categorizes antimicrobials by importance to human medicine, including those authorized exclusively for human use like plazomicin ...

WHO’s Fair Pricing Forum 2024: Enhancing Access to Essential Medicines

The WHO’s virtual Fair Pricing Forum from February 6th to 8th, 2024, focused on equitable access to essential medicines. Stakeholders, including Member States and private sectors, discussed enhancing market transparency and strategies for affordable healthcare. Despite invitation-only participation, the forum emphasized collaboration in addressing global health access challenges. To read more

Urgent Health Advisory: Substandard Medicines Alert – WHO N°8/2023

Medical Product Alert N°8/2023 Substandard (contaminated) syrup and suspension medicines have been identified in multiple WHO regions, including the Americas, Eastern Mediterranean, Southeast Asia, and the Western Pacific. Five products from PHARMIX LABORATORIES (PVT.) LTD, including ALERGO Syrup and ULCOFIN Suspension, have been found with dangerous levels of ethylene glycol, posing severe health risks like ...

Inside the 2023 UN Pharma Quality Summit in Copenhagen

This week, we had the privilege to participate in the 2023 Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers in Copenhagen. It was an opportunity to learn from colleagues about the latest developments around the UN organisations’ approach to pharmaceutical quality assurance and procurement. The session on Regulatory Updates was especially interesting.  It ...

QUAMED Engages in CIP GSG’s Strategic Summit for Regulatory Systems Strengthening

Last week, QUAMED participated in the second formal meeting of the CIP Global Steering Group (GSG) held on 9-10th November 2023 in the Hague, Netherlands. CIP (Coalition of Interested Parties) is a network for regulatory systems strengthening established by the World Health Organization (WHO) to promote a unified, strategic and coordinated approach to national and ...

Substandard (contaminated) syrup medicines identified in the WHO Region of Africa

A batch of NATURCOLD Syrup found in Cameroon has been flagged by WHO as contaminated with diethylene glycol, exceeding safe limits by a shocking 28.6%! This toxic substance can be fatal when consumed and poses serious risks, especially for children. Risks: Abdominal pain, vomiting, diarrhoea, altered mental state, and acute kidney injury leading to death. ...

WHO: Rubella Triumph in South-Asia

Some good news: In just a few years, the WHO South-Asia Region has made incredible strides in controlling rubella. Vaccine coverage has skyrocketed from 12% to 86%, cases have dropped from 5.5 to 1.1 per million, and elimination has been achieved in the Maldives and Sri Lanka. Let’s celebrate this tremendous progress together! For more information ...

WHO Issues Medical Product Alert Regarding Substandard Syrup Medicine

Attention to all. WHO has issued a Medical Product Alert N°4/2023 regarding substandard (contaminated) syrup medicines CRM:0557513. Please check out the WHO website in all 6 UN languages for more information and forward this to relevant end-users, National Regulatory Authorities, procurers, and any other relevant colleagues and organizations. WHO urges increased scrutiny of these products. ...

Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.